全身免疫炎症指数在急性深静脉血栓形成中的评估:一项倾向性匹配研究
该回顾性研究纳入155例急性深静脉血栓(DVT)患者和179例健康对照,经1:1倾向性评分匹配后每组各63例。结果显示DVT组全身免疫炎症指数(SII)、中性粒细胞-淋巴细胞比值(NLR)和血小板-淋巴细胞比值(PLR)均显著升高,SII诊断DVT的曲线下面积(0.861)优于NLR(0.797)和PLR(0.788),作者认为SII可作为静脉血栓的辅助诊断指标。
要点
- DVT组SII、NLR、PLR均高于对照组,差异有统计学意义。
- SII诊断DVT的AUC为0.861,优于NLR(0.797)和PLR(0.788)。
- SII>755.54时诊断敏感性78.1%、特异性73.1%。
核心结论
- SII可作为静脉血栓患者的辅助诊断试验,其敏感性和特异性高于NLR和PLR。
研究设计与样本
- 回顾性分析2017年6月至2021年6月在本院诊断为急性DVT的年龄>18岁患者及无DVT的健康对照。
- 共纳入155例急性DVT患者和179例健康对照,经1:1倾向性评分分析后每组各63例纳入研究。
主要发现
- DVT组血红蛋白、血细胞比容、淋巴细胞计数和血小板分布宽度低于对照组,而白细胞计数、中性粒细胞计数、血小板计数、NLR、PLR、SII和平均血小板体积高于对照组。
- 血红蛋白(P=0.001)、血细胞比容(P=0.001)、白细胞计数(P=0.001)、中性粒细胞计数(P=0.001)、淋巴细胞计数(P=0.001)、血小板计数(P=0.001)、NLR(P=0.001)、PLR(P=0.001)、SII(P=0.001)和平均血小板体积(P=0.031)的变化有统计学意义,血小板分布宽度的变化无统计学意义(P=0.794)。
- NLR的曲线下面积为0.797(95%CI 0.747-0.848;P<0.001),PLR的曲线下面积为0.788(95%CI 0.737-0.840;P=0.01)。
- NLR>3.00时敏感性和特异性分别为71.0%和68.7%,PLR>142.66时分别为70.3%和68.5%。
- SII的曲线下面积为0.861(95%CI 0.820-0.902;P<0.001),SII>755.54时敏感性为78.1%、特异性为73.1%。
关键数值与推荐
- SII>755.54诊断DVT的敏感性78.1%、特异性73.1%,AUC 0.861(95%CI 0.820-0.902;P<0.001)。
- NLR>3.00诊断DVT的敏感性71.0%、特异性68.7%,AUC 0.797(95%CI 0.747-0.848;P<0.001)。
- PLR>142.66诊断DVT的敏感性70.3%、特异性68.5%,AUC 0.788(95%CI 0.737-0.840;P=0.01)。
临床怎么用
- 作者认为SII可作为静脉血栓患者的辅助诊断试验,其敏感性和特异性高于NLR和PLR。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Deep vein thrombosis (DVT) progressing to pulmonary embolism is an important cause of mortality and morbidity worldwide. At present, color Doppler ultrasound is the most effective examination method for the diagnosis of DVT. The systemic immune-inflammation index (SII) has been introduced as a new indicator of comprehensive systemic immune thrombosis and inflammatory status in the body. We believe that the SII might be more specific and sensitive than the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR). In the present study, we aimed to evaluate the predictive potential of the SII, NLR, and PLR in the diagnosis of DVT. METHODS: The data of patients aged >18 years who were diagnosed with acute DVT in our hospital between June 2017 and June 2021 were retrospectively reviewed. During the study period, the data of 155 patients with acute DVT and 179 healthy control patients without DVT were included in the study. A propensity score analysis (1:1) was performed to eliminate differences between the two groups, and 63 patients from each group were included in the present study. RESULTS: When the complete blood count parameters were examined between the patients with acute DVT and the control group, the hemoglobin, hematocrit, lymphocyte count, and platelet distribution width were lower in the DVT group. In contrast, the white blood cell count, neutrophil count, platelet count, NLR, PLR, SII, and mean platelet volume were higher in the DVT group. The changes in hemoglobin (P = .001), hematocrit (P = .001), white blood cell count (P = .001), neutrophil count (P = .001), lymphocyte count (P = .001), platelet count (P = .001), NLR (P=.001), PLR (P = .001), SII (P = .001), and mean platelet volume (P = .031) were significant on statistical analysis. However, the changes in the platelet distribution width were not significant (P = .794). The area under the curve for the NLR and PLR was 0.797 (95% confidence interval [CI], 0.747-0.848; P < .001) and 0.788 (95% CI, 0.737-0.840; P = .01), respectively. The sensitivity and specificity for an NLR >3.00 was 71.0% and 68.7%, respectively. The sensitivity and specificity for a PLR >142.66 was 70.3% and 68.5%, respectively. The area under the curve for SII was 0.861 (95% CI, 0.820-0.902; P < .001), with a sensitivity of 78.1% and specificity of 73.1% for an SII >755.54. CONCLUSIONS: The SII can be used as an auxiliary diagnostic test for patients with venous thrombosis. This parameter is superior to the NLR and PLR with high sensitivity and specificity for patients with venous thrombosis.
引用
- Tort M, Sevil FC, Sevil H, et al. Evaluation of systemic immune-inflammation index in acute deep vein thrombosis: A propensity-matched. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 37003462. doi:10.1016/j.jvsv.2023.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。